Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Dow
Fuji
McKesson
McKinsey
Queensland Health
Cipla
Farmers Insurance

Generated: September 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077204

« Back to Dashboard

NDA 077204 describes CHOLESTYRAMINE, which is a drug marketed by Ani Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Teva, Zydus Pharms Usa Inc, and Teva Pharms, and is included in eleven NDAs. It is available from six suppliers. Additional details are available on the CHOLESTYRAMINE profile page.

The generic ingredient in CHOLESTYRAMINE is cholestyramine. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for 077204
Tradename:CHOLESTYRAMINE
Applicant:Par Pharm
Ingredient:cholestyramine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 077204
Mechanism of ActionBile-acid Binding Activity
Suppliers and Packaging for NDA: 077204
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHOLESTYRAMINE cholestyramine POWDER;ORAL 077204 ANDA Par Pharmaceutical, Inc. 49884-465 49884-465-65 60 PACKET in 1 CARTON (49884-465-65) > 9 g in 1 PACKET (49884-465-64)
CHOLESTYRAMINE cholestyramine POWDER;ORAL 077204 ANDA Par Pharmaceutical, Inc. 49884-465 49884-465-66 378 g in 1 CAN (49884-465-66)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/PACKET
Approval Date:Aug 26, 2005TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/SCOOPFUL
Approval Date:Aug 26, 2005TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Chubb
McKesson
UBS
Federal Trade Commission
Queensland Health
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.